Equities

DermTech Inc

DMTKQ:PKL

DermTech Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.027
  • Today's Change-0.002 / -6.90%
  • Shares traded24.98k
  • 1 Year change-98.40%
  • Beta2.2759
Data delayed at least 15 minutes, as of Sep 20 2024 20:43 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects DermTech Inc share price to rise to 1.50 in the next year from the last price of 0.027.
High5,455.6%1.50
Med5,455.6%1.50
Low5,455.6%1.50

Earnings history & estimates in USD

On May 14, 2024, DermTech Inc reported 1st quarter 2024 losses of -0.58 per share. This result exceeded the -0.62 consensus loss of the 4 analysts covering the company and exceeded last year's 1st quarter results by 43.14%.
Average growth rate+10.89%
DermTech Inc reported annual 2023 losses of -3.09 per share on Feb 29, 2024.
Average growth rate-8.05%
More ▼

Revenue history & estimates in USD

DermTech, Inc. had 1st quarter 2024 revenues of 3.85m. This missed the 3.99m consensus estimate of the 4 analysts following the company. This was 10.58% above the prior year's 1st quarter results.
Average growth rate+2.76%
DermTech, Inc. had revenues for the full year 2023 of 15.30m. This was 5.36% above the prior year's results.
Average growth rate+51.02%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.